GSK : Current Report Of Foreign Issuer - Form 6-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE... | May 12, 2023
Source: marketscreener.com
Page 4 - Steph Mountifield News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Steph Mountifield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Steph Mountifield Today - Breaking & Trending Today
GSK : presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains - Form 6-K
GSK presents pivotal data at ESPID confirming effectiveness of its 5-in-1 meningococcal ABCWY vaccine candidate, with demonstrated coverage against a panel of 110 MenB strains ... | May 12, 2023
Source: marketscreener.com
Statement: Zantac (ranitidine) litigation - Form 6-K
Statement: Zantac litigation GSK plc welcomes the decision of the British Columbia Supreme Court in Dussiaume v. Sandoz Canada Inc. 2023 BCSC 795, dismissing a... | May 12, 2023
Source: marketscreener.com
GSK : European Medicines Agency validates marketing authorisation application for Jemperli (dostarlimab) plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer - Form 6-K
European Medicines Agency validates marketing authorisation application for Jemperli plus chemotherapy for the treatment of dMMR/MSI-H primary advanced or recurrent endometrial cancer ... | April 25, 2023
Source: marketscreener.com
BELLUS Health Inc.: GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough
Source: finanznachrichten.de